ClinicalTrials.gg

Aortic Valve Stenosis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,026 studies for Aortic Valve Stenosis across more than 10 countries. 294 are recruiting or about to start. 859 of them are mainly about Aortic Valve Stenosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 3 narrower conditions too, such as Cardiomyopathy, Hypertrophic: 1,426 studies, 425 open.

ClinicalTrials.gov finds 1,483 studies for Aortic Valve Stenosis. How that becomes 1,024 here

This page counts the studies the registry files under Aortic Valve Stenosis, and those it files under no condition that list Aortic Valve Stenosisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,483Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −381Filed under a narrower condition, counted on its own pageCardiomyopathy, Hypertrophic 347 · Williams Syndrome 29 · Aortic Valve, Calcification of 5
  3. −20List Aortic Valve Stenosis as a condition, but the registry did not file them under itMost often written as “Moderate Aortic Valve Stenosis” (3), “Aortic Stenosis Symptomatic” (2), and “Aortic Stenosis Disease” (2). The registry filed them under other conditions only, most often Mitral Valve Insufficiency (3) and Aortic Valve Disease (3).
  4. −58Match it another way35 name it in the title, 1 in a keyword, and 22 by a synonym or other text the search reads.
  5. 1,024The count on this page34 of them list Aortic Valve Stenosis in their own words; the registry filed them under no condition.

Status

Completed
418
Recruiting
209
Status unknown
138
Active, not recruiting
83
Not yet recruiting
67
Terminated
54

Phase

Phase 4
56
Phase 3
37
Phase 2
29
Phase 1
5
Early Phase 1
4

Where

Germany
191
United States
189
France
131
Italy
118
United Kingdom
107
Netherlands
106

Who develops what

Add Aortic Valve Stenosis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 1 program from 1 company, 1 with this as their studies’ main aim; 1 with a live phase 3 study; 0 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 1 program — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Aortic Valve Stenosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here SGLT2 inhibitors 2 open · Angiotensin receptor blockers (ARBs) 2 open · Mineralocorticoid receptor antagonists (MRAs) 2 open · P2Y12 inhibitors 1 open · Statins 1 open

Coming up

70studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 209 Aortic Valve Stenosis studies recruiting now, 163 (78%) set no upper age limit and 9 (4%) stop at 75 or younger. 25 (12%) take children under 18. 0 (0%) are for women only and 1 (<1%) for men only; 14 (7%) take healthy volunteers.

Recruiting studies that take each age, of 209
AgeWomenMen
1022 (11%)22 (11%)
18153 (73%)153 (73%)
30162 (78%)162 (78%)
40164 (78%)165 (79%)
50172 (82%)173 (83%)
65191 (91%)192 (92%)
75201 (96%)202 (97%)
85192 (92%)193 (92%)

Across all 1,026 studies, recruiting or not: 2% stop at 75 or younger and 1% at 65; 15% take children; <1% are for women only and <1% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Aortic Valve Stenosis studies take

Of 24 phase 4 interventional studies under Aortic Valve Stenosis, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 443 mo26–70 · 24 studies——
Interventional, no phase33 mo18–72 · 288 studies29 mo16–54 · 111 studies47 mo23–79 · 177 studies
Observational44 mo23–86 · 243 studies34 mo21–47 · 37 studies45 mo23–120 · 206 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,026. Browse all 1,026 → or search them.